Synovics Pharmaceuticals·4

Jan 29, 6:40 PM ET

Synovics Pharmaceuticals 4

4 · Synovics Pharmaceuticals · Filed Jan 29, 2009

Insider Transaction Report

Form 4
Period: 2008-09-25
Transactions
  • Purchase

    Series C Convertible Redeemable Preferred Stock

    [F1][F2][F3][F4]
    2008-09-25+1,56025,444,700 total
    Exercise: $0.50From: 2008-09-25Exp: 2011-05-09Common Stock (1,560,000 underlying)
  • Purchase

    Warrant

    [F1][F5]
    2008-09-25+780,00025,444,700 total
    Exercise: $0.75From: 2008-09-25Exp: 2013-09-25Common Stock (780,000 underlying)
Footnotes (5)
  • [F1]See Exhibit 99.1
  • [F2]See Exhibit 99.1
  • [F3]See Exhibit 99.1
  • [F4]See Exhibit 99.1
  • [F5]See Exhibit 99.1
Signature
/s/ Vinay Sapte|2009-01-29

Documents

2 files